Clinical utility of a protein-based oncopanel in patients with end-stage head and neck cancer

Doescher, Johannes; Weissinger, Stephanie E.; Schoensteiner, Stefan S.; Lisson, Catharina; Bullinger, Lars; Barth, Thomas F. E.; Leithaeuser, Frank; Mueller-Richter, Urs; Laban, Simon; Hoffmann, Thomas K.; Möller, Peter; Lennerz, Jochen K.; Schuler, Patrick J.

Erstveröffentlichung

2019

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Doescher, Johannes

Weissinger, Stephanie E.

Schoensteiner, Stefan S.

Lisson, Catharina

Bullinger, Lars

et al.

Institutions

UKU. Klinik für Hals-, Nasen-, Ohrenheilkunde, Kopf- und Halschirurgie
UKU. Institut für Pathologie
UKU. Klinik für Innere Medizin III
UKU. Klinik für diagnostische und interventionelle Radiologie

Published in

Immunotherapy ; 11 (2019), 14. - S. 1193-1203. - ISSN 1750-743X. - eISSN 1750-7448

Link to publication

https://dx.doi.org/10.2217/imt-2019-0041

Keywords

crizotinib; decision making; head and neck cancer; imatinib mesylate; immunohistochemistry; oncopanel; precision oncology; trastuzumab; SQUAMOUS-CELL CARCINOMA; THERAPEUTIC TARGET; MOLECULAR-BIOLOGY; TYROSINE KINASES; EXPRESSION; IMATINIB; MET

Dewey Decimal Group

DDC 610 / Medicine & health

Metadata

Show full item record